Delivery Order SPE2DB20D7066-SPE2DB25FC2VX

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,165.31 firm-fixed-price delivery order is for the supply of CHLORASEPTIC SORE THROAT LOZNG 18S, a medical product, with a performance period ending on September 28, 2023. The award is a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.16 firm fixed-price delivery order is for CHLORASEPTIC MAX 15-10 MG LOZ 15S, a medical product. The contract has an ultimate completion date of March 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.34, is a Firm Fixed Price Delivery Order for the procurement of CHLORASEPTIC MAX 15-10 MG LOZ 15S medical products. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,872.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Chloraseptic Max 15-10 mg lozenges, a product used for pain relief and sore throat treatment. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,111.64, is for the supply of 4,567,926,337 units of Chloraseptic sore throat lozenges. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,121.00, is for the delivery of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 4, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,229.94 Firm Fixed Price Delivery Order contract is for the supply of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a medical product. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the procurement of CHLORASEPTIC SORE THROAT LOZENGES by the Defense Logistics Agency (DLA), a defense agency, from the prime contractor Amerisourcebergen Drug Corp. The award has a ceiling value of $1,347.95 and is a Firm Fixed Price delivery order contract that runs through January 9, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,296.79 firm fixed-price delivery order is for the supply of Chloraseptic Max 15-10 mg lozenges. The contract is not associated with a set-aside program and has an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,338.94, is for the procurement of Chloraseptic Max 15-10 mg lozenges. The contract is a firm fixed-price delivery order, with a period of performance through January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC2VX
    Delivery Order

This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,287.50, is a Firm Fixed Price Delivery Order for the procurement of CHLORASEPTIC SORE THROAT LOZNG 18S medical supplies. The contract has an ultimate completion date of April 3, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/2/25, 10:41 PM